The prognosis for ERMS varies based on several factors, including the tumor's location, size, stage, and the patient's age and overall health. Generally, younger patients and those with localized tumors have a better prognosis. Advances in treatment have significantly improved the survival rates for children with ERMS. However, the prognosis can be poorer for patients with metastatic or recurrent disease.
